COVID-19-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes on SGLT2 inhibitor: a case report

Type 2 diabetes mellitus (DM) patients are at high risk for the development of severe COVID-19. Euglycemic diabetic ketoacidosis (eu-DKA) is a rare life-threatening complication associated with the use of SGLT2 inhibitor that may be unnoticed, particularly in a pandemic setting, due to the absence o...

Descripción completa

Detalles Bibliográficos
Autores principales: Batista, Daniel Valente, Vieira, Carla Antoniana Ferreira de Almeida, Costa, Thomaz Alexandre, Lima, Eduardo Gomes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592186/
https://www.ncbi.nlm.nih.gov/pubmed/33133998
http://dx.doi.org/10.1007/s13340-020-00473-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592186/
https://www.ncbi.nlm.nih.gov/pubmed/33133998
http://dx.doi.org/10.1007/s13340-020-00473-3

Ejemplares similares